Clinical Trial Update: Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Dolcanatide for preventing colorectal cancer in healthy volunteers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Carcinoma

Drugs mentioned

• Dolcanatide (Dolcanatide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colorectal Carcinoma | Phase 1 | Status: COMPLETED | Results posted: 2019-12-17